Compare Abeona Therapeutics Inc (ABEO) vs Ishares Msci Brazil ETF (EWZ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Ishares Msci Brazil ETF — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while Ishares Msci Brazil ETF trades at $34.37. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Ishares Msci Brazil ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | EWZ | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $7.23 | $41.75 |
52-Week Low | $4.17 | $26.52 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
EWZ, the iShares MSCI Brazil ETF, trades at $34.92, up 1.42% over 24 hours, with a bullish technical signal driven by moving averages. The ETF has gained approximately 11% year-to-date, supported by Brazil's monetary easing cycle and commodity strength. Recent news highlights potential as a 2026 sleeper trade if rate cuts proceed, with exposure to Brazilian equities trading at a forward P/E of 9.6x as of Seeking Alpha on 2026-05-05.
Outlook is positive due to asymmetric upside from rate cuts, election repricing, and commodity tailwinds, but risks include Brazil's economic volatility and dependency on Petrobras/Vale dividends. Investors face currency and political uncertainties, though institutional interest remains with new positions like Altfest's $4.72 million investment in Q4 2025 per Defense World on 2026-04-12.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Ishares Msci Brazil ETF
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →
